Publications

Recent publications

• Relationships of PGRN with sTREM2 in AD continuum and non-AD pathophysiology and their reciprocal roles in modulating amyloid pathology: two population-based study
  December 1, 2025
  Relationships of PGRN with sTREM2 in AD continuum and non-AD pathophysiology and their reciprocal roles in modulating amyloid pathology: two population-based studyfor the Alzheimer's Disease Neuroimaging Initiative, Dec 2025, In: Translational psychiatry. 15, 1, 233.Research output: Contribution to journal › Article › peer-review
• Association between self-reported multimorbidity and longitudinal brain Aβ deposition in Alzheimer’s disease
  December 1, 2025
  Association between self-reported multimorbidity and longitudinal brain Aβ deposition in Alzheimer’s diseasefor the Alzheimer's Disease Neuroimaging Initiative, Dec 2025, In: Nature communications. 16, 1, 5905.Research output: Contribution to journal › Article › peer-review
• International application of an optimized harmonization approach for longitudinal cognitive data in people with HIV
  December 1, 2025
  International application of an optimized harmonization approach for longitudinal cognitive data in people with HIVLang, L., Rubin, L. H., Ances, B. M., Anok, A., Cooley, S., Dastgheyb, R. M., Easter, R. E., Franklin, D. R., Heaton, R. K., Letendre, S. L., Nakijozi, G., Marcotte, T., Paul, R., Shorer, E. F., Tomusange, S., Vance, D. E. & Xu, Y., Dec 2025, In: Journal of Clinical Epidemiology. 188, 111972.Research output: Contribution to journal › Article › peer-review
• Development and evaluation of image preprocessing pipelines for the Centiloid method on Down Syndrome data
  October 1, 2025
  Development and evaluation of image preprocessing pipelines for the Centiloid method on Down Syndrome dataAlzheimer's Biomarkers Consortium-Down Syndrome (ABC-DS) Investigators, Oct 1 2025, In: Alzheimer's & dementia : the journal of the Alzheimer's Association. 21, 10, p. e70712Research output: Contribution to journal › Article › peer-review
• Ruling in, ruling out: the clinical utility of plasma biomarkers in diagnosis of Alzheimer's disease
  October 1, 2025
  Ruling in, ruling out: the clinical utility of plasma biomarkers in diagnosis of Alzheimer's diseaseWisch, J. K. & Ances, B. M., Oct 1 2025, In: The Journal of clinical investigation. 135, 19Research output: Contribution to journal › Article › peer-review
• GATA2 mutation is associated with immune dysfunction and increased Mycobacterium haemophilum susceptibility in immunocompromised individuals
  September 23, 2025
  GATA2 mutation is associated with immune dysfunction and increased Mycobacterium haemophilum susceptibility in immunocompromised individualsAbhimanyu, Sep 23 2025, In: JCI Insight. 10, 18Research output: Contribution to journal › Article › peer-review
• Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathology
  September 1, 2025
  Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathologyRafii, M. S., Schlachetzki, Z., Barroeta, I., Head, E., Fortea, J. & Ances, B. M., Sep 2025, In: The Lancet Neurology. 24, 9, p. 753-762 10 p.Research output: Contribution to journal › Review article › peer-review
• Sex Differences in the Neurovascular Health of Aging Adults
  August 1, 2025
  Sex Differences in the Neurovascular Health of Aging Adultsfor the HABS-HD Study Team, Aug 1 2025, In: Stroke. 56, 8, p. 2177-2189 13 p.Research output: Contribution to journal › Article › peer-review
• Scalable quality control on processing of large diffusion-weighted and structural magnetic resonance imaging datasets
  August 1, 2025
  Scalable quality control on processing of large diffusion-weighted and structural magnetic resonance imaging datasetsthe Alzheimer's Disease Neuroimaging Initiative & the HABS-HD Study Team, Aug 2025, In: PloS one. 20, 8 August, e0327388.Research output: Contribution to journal › Article › peer-review
• Interpreting the evidence on gantenerumab for dominantly inherited Alzheimer's disease – Authors' reply
  August 1, 2025
  Interpreting the evidence on gantenerumab for dominantly inherited Alzheimer's disease – Authors' replyDominantly Inherited Alzheimer's Disease–Trials Unit, Aug 2025, In: The Lancet Neurology. 24, 8, p. 635-636 2 p.Research output: Contribution to journal › Letter › peer-review